Cargando…
Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a “Danger Signal” to Block Immune Escape of Tumor Cells
Immune escape of tumor cells is one of the main obstacles hindering the effectiveness of cancer immunotherapy. We developed a novel strategy to block immune escape by transfecting tumor cells in vivo with genes of pathogenic antigens from Mycobacterium tuberculosis (TB). This induces presentation of...
Autores principales: | Koyama, Yoshiyuki, Yoshihara, Chieko, Ito, Tomoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588192/ https://www.ncbi.nlm.nih.gov/pubmed/26213962 http://dx.doi.org/10.3390/pharmaceutics7030165 |
Ejemplares similares
-
Highly Effective Non-Viral Antitumor Gene Therapy System Comprised of Biocompatible Small Plasmid Complex Particles Consisting of pDNA, Anionic Polysaccharide, and Fully Deprotected Linear Polyethylenimine
por: Koyama, Yoshiyuki, et al.
Publicado: (2015) -
Innate immunity mediated by dendritic cells/macrophages plays a central role
in the early period in tumor treatment using gene of Mycobacterium tuberculosis
antigen
por: USHIGUSA, Takahiro, et al.
Publicado: (2018) -
The Immune Escape Mechanisms of Mycobacterium Tuberculosis
por: Zhai, Weijie, et al.
Publicado: (2019) -
Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells
por: Ito, Tomoko, et al.
Publicado: (2021) -
Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger
por: Salina, Elena G., et al.
Publicado: (2022)